Mohammad Atiq
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Prostate Cancer Treatment and Research 14
- Ferroptosis and cancer prognosis 2
- Oncology 13
- Cancer Immunotherapy and Biomarkers 10
- PARP inhibition in cancer therapy 2
- Co-authors
- Issam Makhoul (1 shared paper)Thomas Kieber‐Emmons (1 shared paper)Subhiksha Nandakumar (5 shared papers)Goutam Chakraborty (7 shared papers)Yuki Yoshikawa (6 shared papers)Philip W. Kantoff (7 shared papers)Gwo‐Shu Mary Lee (6 shared papers)Ying Z. Mazzu (7 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Cancer Research (2 papers)Molecular Oncology (1 paper)Expert Review of Anticancer Therapy (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesNew ZealandJapan
In The Last Decade
Mohammad Atiq
20 papers receiving 160 citations
Peers
Comparison fields: 5 of 45
- Oncology 77
- Immunology 46
- Pulmonary and Respiratory Medicine 57
- Cancer Research 23
- Genetics 6
Countries citing papers authored by Mohammad Atiq
This map shows the geographic impact of Mohammad Atiq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Atiq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Atiq more than expected).
Fields of papers citing papers by Mohammad Atiq
This network shows the impact of papers produced by Mohammad Atiq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Atiq. The network helps show where Mohammad Atiq may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Atiq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 59 | |
| 2 | 2020 | 24 | |
| 3 | 2020 | 18 | |
| 4 | 2009 | 11 | |
| 5 | 2023 | 9 | |
| 6 | 2020 | 7 | |
| 7 | 2020 | 5 | |
| 8 | 2022 | 4 | |
| 9 | 2018 | 4 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 3 | |
| 12 | 2014 | 3 | |
| 13 | 2021 | 3 | |
| 14 | 2018 | 2 | |
| 15 | 2021 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2018 | 1 |
About Mohammad Atiq
Mohammad Atiq is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Cancer Research, having authored 22 papers that have together received 161 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (14 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Research and Treatments (3 papers), Ferroptosis and cancer prognosis (2 papers), Cancer, Lipids, and Metabolism (2 papers), PARP inhibition in cancer therapy (2 papers), Immunotherapy and Immune Responses (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Oncology (77 citations), Immunology (46 citations), Pulmonary and Respiratory Medicine (57 citations), Cancer Research (23 citations) and Genetics (6 citations). Mohammad Atiq has collaborated with scholars based in United States, New Zealand and Japan. Frequent co-authors include Issam Makhoul, Thomas Kieber‐Emmons, Subhiksha Nandakumar, Goutam Chakraborty, Yuki Yoshikawa, Philip W. Kantoff, Gwo‐Shu Mary Lee, Ying Z. Mazzu, Fatima Karzai and Ravi A. Madan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Molecular Oncology, Expert Review of Anticancer Therapy and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.